Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Journey Medical Corporation (DERM) had Revenue of $17.63M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$17.63M
Net Income	$-2.31M
Cost of Goods Sold	$5.75M
Gross Profit	$11.88M
Operating Expenses	$19.16M
Operating Income	$-1.53M
Non-Operating Income/Expense	$-0.79M
Pre-Tax Income	$-2.31M
Normalized Pre-Tax Income	$-2.31M
Income after Taxes	$-2.31M
Income from Continuous Operations	$-2.31M
Consolidated Net Income/Loss	$-2.31M
Normalized Income after Taxes	$-2.31M
EBIT	$-1.53M
EBITDA	$-0.32M
Weighted-Average Shares Outstanding (Basic)	24.96M
Weighted-Average Shares Outstanding (Diluted)	24.96M
Earnings per Share (EPS) (Basic)	$-0.09
Earnings per Share (EPS) (Diluted)	$-0.09
Balance Sheet Financials
Current Assets	$56.39M
Property, Plant, and Equipment	--
Long-Term Assets	$28.80M
Total Assets	$85.19M
Current Liabilities	$39.72M
Long-Term Debt	$19.53M
Long-Term Liabilities	$19.58M
Total Liabilities	$59.29M
Common Equity	$25.90M
Tangible Shareholders Equity	$-2.77M
Shareholders Equity	$25.90M
Common Shares Outstanding	26.37M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-6.16M
Cash Flow from Investing Activities	--
Cash Flow from Financial Activities	$10.80M
Beginning Cash	$20.30M
End Cash	$24.95M
Increase/Decrease in Cash	$4.64M
Stock-Based Compensation	$4.51M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.42
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.43
Debt to Equity Ratio	0.97
Gross Margin	67.36%
Operating Margin	-8.67%
EBIT Margin	-8.67%
EBITDA Margin	--
Pre-Tax Profit Margin	-13.13%
Profit Margin	-13.13%
Free Cash Flow	$-6.16M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.21
Inventory Turnover	0.49
Receiveable Turnover	0.98
Days Sales in Receivables	91.80
Return on Equity	-8.94%
Return on Tangible Equity	83.51%
Return on Assets	-2.72%
Return on Investments	-5.10%
Book Value Per Share	$0.98
Free Cash Flow per Share	$-0.25
Operating Cash Flow per Share	$-0.25

Data from Zacks Investment Research, Inc.